Matches in Wikidata for { <http://www.wikidata.org/entity/Q33364191> ?p ?o ?g. }
- Q33364191 description "2005 nî lūn-bûn" @default.
- Q33364191 description "2005 թուականի Յունուարին հրատարակուած գիտական յօդուած" @default.
- Q33364191 description "2005 թվականի հունվարին հրատարակված գիտական հոդված" @default.
- Q33364191 description "2005年の論文" @default.
- Q33364191 description "2005年論文" @default.
- Q33364191 description "2005年論文" @default.
- Q33364191 description "2005年論文" @default.
- Q33364191 description "2005年論文" @default.
- Q33364191 description "2005年論文" @default.
- Q33364191 description "2005年论文" @default.
- Q33364191 description "2005年论文" @default.
- Q33364191 description "2005年论文" @default.
- Q33364191 description "2005年论文" @default.
- Q33364191 description "2005年论文" @default.
- Q33364191 description "2005年论文" @default.
- Q33364191 description "2005년 논문" @default.
- Q33364191 description "article científic" @default.
- Q33364191 description "article scientific" @default.
- Q33364191 description "article scientifique (publié 2005)" @default.
- Q33364191 description "articol științific" @default.
- Q33364191 description "articolo scientifico" @default.
- Q33364191 description "artigo científico (publicado na 2005)" @default.
- Q33364191 description "artigo científico (publicado na 2005)" @default.
- Q33364191 description "artigo científico" @default.
- Q33364191 description "artikull shkencor" @default.
- Q33364191 description "artikulong pang-agham" @default.
- Q33364191 description "artykuł naukowy" @default.
- Q33364191 description "artículo científico publicado en 2005" @default.
- Q33364191 description "artículu científicu espublizáu en 2005" @default.
- Q33364191 description "bilimsel makale" @default.
- Q33364191 description "bài báo khoa học" @default.
- Q33364191 description "mokslinis straipsnis" @default.
- Q33364191 description "naučni članak" @default.
- Q33364191 description "scienca artikolo" @default.
- Q33364191 description "scientific article" @default.
- Q33364191 description "teaduslik artikkel" @default.
- Q33364191 description "tieteellinen artikkeli" @default.
- Q33364191 description "tudományos cikk" @default.
- Q33364191 description "vedecký článok" @default.
- Q33364191 description "vetenskaplig artikel" @default.
- Q33364191 description "videnskabelig artikel (udgivet 2005)" @default.
- Q33364191 description "vitenskapelig artikkel" @default.
- Q33364191 description "vitskapeleg artikkel" @default.
- Q33364191 description "vědecký článek" @default.
- Q33364191 description "wetenschappelijk artikel" @default.
- Q33364191 description "wissenschaftlicher Artikel" @default.
- Q33364191 description "επιστημονικό άρθρο" @default.
- Q33364191 description "мақолаи илмӣ" @default.
- Q33364191 description "мақолаи илмӣ" @default.
- Q33364191 description "наукова стаття, опублікована в січні 2005" @default.
- Q33364191 description "научна статия" @default.
- Q33364191 description "научная статья" @default.
- Q33364191 description "научни чланак" @default.
- Q33364191 description "научни чланак" @default.
- Q33364191 description "מאמר מדעי" @default.
- Q33364191 description "سائنسی مضمون" @default.
- Q33364191 description "مقالة علمية" @default.
- Q33364191 description "مقالهٔ علمی" @default.
- Q33364191 description "২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33364191 description "บทความทางวิทยาศาสตร์" @default.
- Q33364191 description "სამეცნიერო სტატია" @default.
- Q33364191 name "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study" @default.
- Q33364191 name "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study" @default.
- Q33364191 name "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study" @default.
- Q33364191 type Item @default.
- Q33364191 label "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study" @default.
- Q33364191 label "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study" @default.
- Q33364191 label "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study" @default.
- Q33364191 prefLabel "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study" @default.
- Q33364191 prefLabel "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study" @default.
- Q33364191 prefLabel "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study" @default.
- Q33364191 P1433 Q33364191-A7CBEA02-0A09-4C3C-BB49-C1D62801F568 @default.
- Q33364191 P1476 Q33364191-D2355C08-3EE4-45D5-A840-2254414254DD @default.
- Q33364191 P2093 Q33364191-14224959-A35D-4382-B185-C92A863639A0 @default.
- Q33364191 P2093 Q33364191-2EB86DF9-2C73-40E5-99AE-CEB1BC2D0ECB @default.
- Q33364191 P2093 Q33364191-6B371F21-CDA6-4C75-ADEC-540CA311FC6E @default.
- Q33364191 P2093 Q33364191-7A1D76D7-5DE3-470F-A8AF-D8BC14C6F4AD @default.
- Q33364191 P2093 Q33364191-9FBF5118-ADD4-48D5-8EF9-70022BF036EE @default.
- Q33364191 P2093 Q33364191-BF8FEBCA-512A-4DED-92A2-9BC65A12B48E @default.
- Q33364191 P2093 Q33364191-C69032CF-5CA4-434B-B4A0-2D87DD619F4F @default.
- Q33364191 P2093 Q33364191-D86FB1AA-B66C-466C-95E1-0F3A2FBF3492 @default.
- Q33364191 P2093 Q33364191-DFFE052F-FBD5-4754-A0D4-93D12B0448F2 @default.
- Q33364191 P2093 Q33364191-F85CF4F6-6DEB-4122-ADFA-77A63C0CD1DB @default.
- Q33364191 P2093 Q33364191-F94F1E1C-1BC9-4A28-94BD-3CD588EB3E27 @default.
- Q33364191 P304 Q33364191-66045488-FAAB-49E8-A645-F14A144FB271 @default.
- Q33364191 P31 Q33364191-30A28DA5-0D69-4C11-9890-34D3397482E1 @default.
- Q33364191 P356 Q33364191-0188A1BB-754E-4B96-B50A-2BFCCC8D61DA @default.
- Q33364191 P407 Q33364191-25DA9C13-4FDD-4829-9907-8F49DC5A7055 @default.
- Q33364191 P433 Q33364191-AFED379C-4FFC-4C44-9580-2CC43F12F95E @default.
- Q33364191 P478 Q33364191-765CABDE-7DD9-46A5-8B67-E3825522EBBC @default.
- Q33364191 P577 Q33364191-DECCA2DD-68DF-4661-8C78-CA242631787A @default.
- Q33364191 P5875 Q33364191-F98F219C-8D64-4F21-9A11-A392FD7EC17F @default.
- Q33364191 P698 Q33364191-7219CD85-7B38-4D15-A897-288C42AD90FD @default.
- Q33364191 P921 Q33364191-04D00FD0-E6A6-40F5-A964-68A9EA7E3663 @default.
- Q33364191 P921 Q33364191-84156DDD-AEEF-4943-8BD0-1096A60F34D5 @default.
- Q33364191 P921 Q33364191-FE4EEE78-5E82-47C9-9CB0-1F44182B42C4 @default.
- Q33364191 P356 J.1365-2141.2004.05281.X @default.
- Q33364191 P698 15606549 @default.
- Q33364191 P1433 Q4970200 @default.
- Q33364191 P1476 "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study" @default.